Jordi Camí

Q: What Schools Are Affiliated With Jordi Camí

Jordi Camí is affiliated with the following schools: Autonomous University of Barcelona, Pompeu Fabra University, University of Barcelona

Jordi Camí's AcademicInfluence.com Rankings

Jordi Camí

Medical

#2488

World Rank

#2915

Historical Rank

Pharmacology

#336

World Rank

#387

Historical Rank

medical Degrees

Download Badge

Medical

Jordi Camí's Degrees

PhD Pharmacology University of Barcelona

Why Is Jordi Camí Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jordi Camí is Professor of Pharmacology at Pompeu Fabra University, General Director of the Barcelona Biomedical Research Park , and vice president of the Pasqual Maragall Foundation. He has been the promoter and first director of the Pasqual Maragall Foundation between 2008 and 2020. His scientific activity has been focused on the field of Neurosciences , having explored other fields such as Bibliometry, Evaluation and Scientific Policy. His academic activity has been carried out between the Autonomous University of Barcelona and the Pompeu Fabra University , having held the positions of Delegate of the Rector, Dean and Director of the department. At the UPF, he promoted Biology studies and the creation and development of the Department of Experimental and Health Sciences. He was the Director of the IMIM between 1985 and 2005. He has also participated in the creation of new research centers and, in particular, the PRBB, which he founded and runs since 2005. He founded the no longer edited journal Quark .

(See a Problem?)

Jordi Camí's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. (2004) (403)
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. (2000) (367)
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. (1999) (337)
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. (2000) (224)
Alcohol and cocaine interactions in humans. (1993) (192)
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. (2002) (188)
3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. (2002) (173)
Pharmacology of MDMA in Humans (2000) (165)
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics (2004) (149)
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. (1997) (138)
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. (2002) (111)
Drug addiction. (2003) (109)
Psychotropic drug consumption and other factors associated with heroin overdose. (1994) (104)
Pharmacokinetic considerations in abuse liability evaluation. (1991) (104)
Neuropsychological performance in opiate addicts after rapid detoxification. (1987) (97)
The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease (2016) (95)
Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts. (1991) (85)
[Spanish scientific production in biomedicine and health sciences during the period 1990-1993 (Science Citation Index and Social Science Citation Index) and comparison to period 1986-1989]. (1997) (81)
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers (2019) (71)
Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort (2018) (70)
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection. (1999) (66)
[Spanish scientific production in biomedicine and health. A study via the Science Citation Index (1986-1989)]. (1993) (66)
Accumulation of caffeine in healthy volunteers treated with furafylline. (1987) (64)
Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification. (1993) (63)
Cocaine metabolism in humans after use of alcohol. Clinical and research implications. (1998) (59)
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers (2005) (57)
Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. (1992) (55)
Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. (1990) (55)
Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). (1994) (55)
Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin (1985) (54)
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit (2016) (52)
Effect of quinolones on caffeine disposition (1989) (52)
Immunomodulating Activity of MDMA (2000) (50)
Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. (1992) (48)
Abuse liability of flunitrazepam among methadone-maintained patients (1998) (47)
Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults (2020) (44)
Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort (2019) (42)
The relevance of urinary cocaethylene following the simultaneous administration of alcohol and cocaine. (1991) (40)
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. (2001) (39)
Success and failure at inpatient heroin detoxification. (1989) (39)
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart (2013) (37)
White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes (2018) (36)
Is there an association between the quality of hospitals’ research and their quality of care? (2010) (31)
Follow-up of heroin addicts in Spain (EMETYST project): results 1 year after treatment admission. (1988) (30)
Determination of cocaine and its metabolites in human urine by gas chromatography/mass spectrometry after simultaneous use of cocaine and ethanol. (1995) (28)
Analysis of biomedical research in Spain (1995) (28)
A multicentre study to introduce naltrexone for opiate dependence in Spain. (1989) (27)
Diclofenac versus dipyrone in acute renal colic: A double-blind controlled trial (2004) (27)
Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes (1991) (27)
Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry. (1999) (26)
Creating a transatlantic research enterprise for preventing Alzheimer's disease (2009) (24)
Proficiency testing on drugs of abuse: one year's experience in Spain. (1989) (23)
Simultaneous detection in urine of cocaine and its main metabolites. (1990) (23)
[The consumption of drugs in Spain and its position in European context]. (1993) (23)
Sensation seeking amongst healthy volunteers participating in phase I clinical trials. (1995) (22)
Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children. (1986) (21)
Acute Effects of Tramadol in Methadone-Maintained Volunteers (2012) (21)
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4h apart Human pharmacology of MDMA after repeated doses taken 4h apart (2015) (20)
Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45–75: Results from the ALFA study (2017) (20)
Does Peer Review Predict the Performance of Research Projects in Health Sciences? (2004) (19)
Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family). (2015) (19)
A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers (1996) (18)
Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers. (1994) (16)
Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients. (1994) (15)
Epidemiological surveillance of opioid-related episodes in an emergency room of Barcelona, Spain (1979-1989) (1991) (13)
Personality of healthy volunteers participating in phase I clinical trials (1989) (13)
Detection and quantification of non-steroidal anti-inflammatory agents by gas chromatography/mass spectrometry: diclofenac. (1988) (13)
Substance use among medical students in Barcelona (Spain). A comparison with previous surveys. (1986) (13)
Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioids. (1999) (12)
Buprenorphine versus heroin dependence: comparison of toxicologic and psychopathologic characteristics. (1993) (12)
152 PHARMACOKINETICS OF ECSTASY (MDMA) IN HEALTHY SUBJECTS (1997) (11)
Acute poisoning in Barcelona, Spain. (1980) (11)
Alcoholism among inpatients in a general hospital in Barcelona, Spain. (1988) (11)
HIGHER PREVALENCE OF CEREBRAL WHITE MATTER HYPERINTENSITIES IN HOMOZYGOUS APOE-ε4 ALLELE CARRIERS AGED 45 TO 75: RESULTS FROM THE ALFA STUDY (2017) (11)
Caffeine, tobacco, alcohol and drug consumption among medical students in Barcelona (1977) (11)
Effects of morphine in postaddict humans: a meta-analysis. (1994) (10)
MONITORING COCAINE EPIDEMICS IN BARCELONA (1987) (10)
[Medicina Clinica (1992-1993) seen through the Science Citation Index]. (1997) (10)
Alcohol antagonism of hypercortisolism induced by naloxone (1988) (9)
[Bibliometric map of Spain 1994-2002: biomedicine and health sciences]. (2005) (8)
[Bibliometric map of Spain 1996-2004: biomedicine and health sciences]. (2008) (7)
Interaction of cocaine with ethanol. (1990) (6)
Identification and bibliometric characterization of research groups in the cardio-cerebrovascular field, Spain 1996-2004. (2012) (6)
Playing magic tricks to deep neural networks untangles human deception (2019) (5)
Human drug abuse liability: testing times ahead. (1991) (5)
[Ecstasy, the drug of the route of bakalao]. (1996) (4)
[Outcome of a sample of heroin addicts 2 years after the beginning of treatment (project EMETHYST)]. (1989) (4)
Comment: Use and Abuse of Flunitrazepam (1998) (4)
Double blind assessment of buprenorphine withdrawal in opiate-addicts. (1990) (3)
On the cognitive bases of illusionism (2020) (3)
[Clinical effectiveness of naloxone in acute ethanol intoxication]. (1993) (3)
[The risk factors in death from heroin]. (1995) (3)
Perspectives and future on testing for abuse liability in humans. (1991) (3)
[Conflict of interest and clinical research]. (1995) (3)
Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals (2019) (3)
[Acute poisonings in Barcelona. Epidemiology and therapeutic considerations (author's transl)]. (1980) (2)
Evaluation of Urinary Elimination of N-Acetyl-β-Glucosaminidase in Healthy Volunteers Treated with Dibekacin or Gentamicin (1982) (2)
[Acute fatal poisoning caused by methylenedioxyamphetamine]. (1996) (2)
Thermal Degradation of Cocaine and Its Metabolites in Gas Chromatography. A Source of Errors When Interpreting Metabolic Results (1993) (2)
[Toxicity of ecstasy]. (1998) (2)
TOXICIDAD DEL EXTASIS (1998) (2)
[Heroin: a new cause of toxicological emergencies]. (1984) (2)
Long-term memory of real-world episodes is independent of recency effects: magic tricks as ecological tasks (2020) (1)
Symposium 13: Drugs of abuse: Metabolism, analysis and clinical implications (1990) (1)
Comprehensive gas chromatographic analysis of heroin street samples. (1988) (1)
Inpatient Heroin Detoxification: the authors' reply to Cook (1989) (1)
[International diffusion of Spanish research on drug dependence]. (1988) (1)
[Toxicologic research in Spain as seen through the databases (1985-1986)]. (1988) (1)
General and risk management, patient safety (2013) (1)
Science as Magic (2020) (1)
More on opioid overdose. (1999) (1)
The effects of HIV infection on the development of methadone maintenance treatment in Spain. (1994) (1)
[Treatment of acute pain in a general hospital: opinions of physicians and nurses]. (1992) (1)
[Notes on the bibliometric context of Revista Espanola de Cardiologia]. (2007) (1)
NOTAS PARA LA HISTORIA DEL CENTENARIO DEL BALONCESTO ESPAÑOL. UN DEPORTE ESCOLAR Y POPULAR PARA AMBOS SEXOS (1897-1938) Notes for the history of the Spanish basketball centenary. A school and popular sport for both sexes (1897-1938) (2014) (1)
[Impactolatry: diagnosis and treatment]. (1997) (1)
[External and institutional control of clinical research]. (1994) (0)
[Evaluation activities a symptom of good health]. (1999) (0)
Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort (2019) (0)
Pharmacological effects of ecstasy in humans (1997) (0)
The need for instruments both fantastic and mythical (1994) (0)
[Why does one become addicted to heroin?]. (1984) (0)
[Is the incidence of heroin addiction diminishing in Spain?]. (1988) (0)
[Pathological processes in 176 heroin addicts admitted at a general hospital]. (1984) (0)
Consumption of benzodiazepines in heroin addicts admitted for inpatient detoxification between 1982 and 1991 (1992) (0)
[Animal experimentation and progress in medicine]. (2014) (0)
[Sabbatical leave, vacation or work?]. (1995) (0)
Bioethical challenges in personalised medicine (2012) (0)
COMMENT ON : USE AND ABUSE OF FLUNITRAZEPAM. AUTHOR'S REPLY (1998) (0)
[Acute urticaria. Retrospective epidemiologic study in a general hospital of Barcelona]. (1980) (0)
A public good book (2006) (0)
1372 – CAFFEIN, TOBACCO AND ALCOHOL CONSUMPTION AMONG MEDICAL STUDENTS IN SPAIN (1977) (0)
[Prioritization of biomedical research: implications for investigation in public health and health services]. (2000) (0)
INFLUENCE OF GUANETHIDINE INDUCED NORADRENALINE DEPLETION ON THE ISOLATED RAT VAS DEFERENS RESPONSE TO TYRAMINE (1978) (0)
[Is it necessary to change the regulation in which drugs are not the objective of the medical research?]. (2012) (0)
Double-blind assessment of buprenorphine withdrawal in opiate-addicts. (1990) (0)
[Evaluation of biomedical research]. (2001) (0)
Teaching pharmacology to biology and medical students at the Pompeu Fabra University (2000) (0)
Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort (2018) (0)
[Cocaine: the epidemic to come]. (1988) (0)
Volunteering for research (1992) (0)
[Strenghts and weaknesses of peer review]. (2008) (0)
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers (2019) (0)
2395 – INFLUENCE OF PRETREATMENT WITH DIFFERENT MAO INHIBITORS ON THE TYRAMINE INDUCED DEPLETION IN THE HEART AND VAS DEFERENS OF THE RAT (1978) (0)
or Gentamicin Volunteers Treated with-Glucosaminidase in Healthy β-Acetyl-N Elimination of Evaluation of Urinary (2003) (0)
[Drug promotion, scientific promotion, and conflict of interest. On the royal decree 1416/1994, which regulates drug advertising]. (1995) (0)
White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes (2018) (0)
[Rehabilitation of heroin addicts: definition, criteria and problems of evaluation and follow-up studies]. (1986) (0)
Heroin intoxication: the relation between plasma morphine concentration and clinical state at admission (2004) (0)
Volunteering for research (1992) (0)
Estudios y tópicos: Los transtornos que se utilizan en contra del cannabis (1997) (0)
Public Outreach Through the Cronyn Observatory (Abstract) (2019) (0)
Analysis of biomedical research in Spain I . G 6 mez (2003) (0)
Implementation of a testing and quality control program (1990) (0)
[Cardiovascular and neuropsychologic changes during detoxification of heroin addicts with clonidine]. (1984) (0)
GRP-033 Benzodiazepine Drug Abuse Among Intravenous Drug Users (2013) (0)
1371 – DRUG TAKING AMONG MEDICAL STUDENTS IN SPAIN (1977) (0)
The Illusionist Brain (2022) (0)
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart (2012) (0)
On the Cognitive Bases of Illusionism: An Untapped Tool for Brain and Behavioral Research (2020) (0)

This paper list is powered by the following services:

Other Resources About Jordi Camí

What Schools Are Affiliated With Jordi Camí?

Jordi Camí is affiliated with the following schools:

Jordi Camí's Academic­Influence.com Rankings